ArticlePloS one2025
Burden of chronic respiratory disease in Fujian province, 1990-2021.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic respiratory diseases (CRDs) are major public health problems with significant risk factors. This study aimed to analyze the disease burden and attributable risk factors of CRDs in Fujian, Southeast China, between 1990 and 2021 and provide a scientific basis for developing public health policies for Fujian government.
methodsData on incidence, prevalence, deaths, disability-adjusted life years (DALYs), and attributable risk factors for CRDs among Fujian residents were estimated as part of the Global Burden of Disease 2021 (GBD 2021) study at the provincial level. Joinpoint regression was used to assess the long-term temporal trends of the disease burden and identify the main risk factors of CRD between 1990 and 2021.
resultsIn 1990, there were 0.22 million (95% CI: 0.20-0.28) new CRD cases and 1.56 million (95% CI: 1.38-1.78) patients with CRDs, increasing up to 0.24 million (95% CI: 0.21-0.28) new cases and 2.00 million (95% CI: 1.80-2.24) patients with CRDs in 2021. However, the age-standardized incidence rate, age-standardized prevalence rate, age-standardized mortality rate, and age-standardized DALY rate decreased by 29.63%, 29.26%, 75.92%, and 73.62% in Fujian (all P < 0.01) in these 32 years. The DALYs for CRDs were higher in males, patients older than 50 years, and patients with COPD. Smoking, ambient particulate matter pollution, and occupational exposure were the top three attributable risk factors of DALYs for CRDs in Fujian in 2021. Moreover, the proportion attributed to household air pollution from solid fuels significantly decreased.
conclusionThe total CRD burden in Fujian province decreased, but the number of new cases and patients continuously increased. The ranking of risk factors of CRDs has changed between 1990 and 2021. Older men, smokers, and people with occupational exposure were the key groups that relieved the CRD burden. Efforts should focus on quitting smoking and reducing air pollution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.